Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life. | J Clin Gastroenterol | 2022 | 35997709 | PubTator, text mining | PubMed |
| Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality. | Hepatol Commun | 2022 | 35972345 | PubTator, text mining | PubMed |
| Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study. | Drugs Real World Outcomes | 2022 | 35962921 | PubTator, text mining | PubMed |
| Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug. | Signal Transduct Target Ther | 2022 | 35961979 | PubTator, text mining | PubMed |
| Effects of Suramin on Polycystic Kidney Disease in a Mouse Model of Polycystin-1 Deficiency. | Int J Mol Sci | 2022 | 35955634 | PubTator, text mining | PubMed |
| Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells. | J Thromb Haemost | 2022 | 35950488 | PubTator, text mining | PubMed |
| Psychogenic Polydipsia in a Patient With a Clinical Triad. | Cureus | 2022 | 35949782 | PubTator, text mining | PubMed |
| Allosteric modulation of GPCR-induced β-arrestin trafficking and signaling by a synthetic intrabody. | Nat Commun | 2022 | 35941121 | PubTator, text mining | PubMed |
| G protein-coupled receptor kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by chemokine receptor CXCR4. | J Biol Chem | 2022 | 35940305 | PubTator, text mining | PubMed |
| The Use of Indomethacin for Nocturnal Enuresis in Children With Nephrogenic Diabetes Insipidus: A Case Report and Review of the Literature. | Can J Kidney Health Dis | 2022 | 35923182 | PubTator, text mining | PubMed |
| Investigation of dirigent like domains from bacterial genomes. | BMC Bioinformatics | 2022 | 35918655 | PubTator, text mining | PubMed |
| The Utility of Small Fishes for the Genetic Study of Human Age-Related Disorders. | Front Genet | 2022 | 35910227 | PubTator, text mining | PubMed |
| X-linked genetic risk factors that promote autoimmunity and dampen remyelination are associated with multiple sclerosis susceptibility. | Mult Scler Relat Disord | 2022 | 35905688 | PubTator, text mining | PubMed |
| Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic diabetes insipidus. | J Recept Signal Transduct Res | 2022 | 35901021 | PubTator, text mining | PubMed |
| The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers. | Front Cardiovasc Med | 2022 | 35898267 | PubTator, text mining | PubMed |
| A 3D In Vivo Model for Studying Human Renal Cystic Tissue and Mouse Kidney Slices. | Cells | 2022 | 35892566 | PubTator, text mining | PubMed |
| Vasopressin Receptor Type-2 Mediated Signaling in Renal Cell Carcinoma Stimulates Stromal Fibroblast Activation. | Int J Mol Sci | 2022 | 35886951 | PubTator, text mining | PubMed |
| High Oxytocin Receptor Expression Linked to Increased Cell Migration and Reduced Survival in Patients with Triple-Negative Breast Cancer. | Biomedicines | 2022 | 35884900 | PubTator, text mining | PubMed |
| NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression. | Technol Cancer Res Treat | 2022 | 35880269 | PubTator, text mining | PubMed |
| dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells. | Front Cell Dev Biol | 2022 | 35874817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=25